首页 | 本学科首页   官方微博 | 高级检索  
     


Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease
Authors:Kenneth Cusi  Zhi Chang  Steve Harrison  Romina Lomonaco  Fernando Bril  Beverly Orsak  Carolina Ortiz-Lopez  Joan Hecht  Ariel E. Feldstein  Amy Webb  Christopher Louden  Martin Goros  Fermin Tio
Affiliation:1 Divisions of Endocrinology, Diabetes and Metabolism, University of Florida, Gainesville, FL, United States;2 Division of Diabetes, The University of Texas Health Science Center at San Antonio (UTHSCSA), United States;3 Division of Hepatology, The University of Texas Health Science Center at San Antonio (UTHSCSA), United States;4 Department of Epidemiology and Biostatistics, The University of Texas Health Science Center at San Antonio (UTHSCSA), United States;5 Department of Pathology, The University of Texas Health Science Center at San Antonio (UTHSCSA), United States;6 Brooke Army Medical Center, San Antonio, TX, United States;7 Audie L. Murphy Veterans Administration Medical Center (VAMC), San Antonio, TX, United States;8 Malcom Randall VAMC, Gainesville, FL, United States;9 Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Professor of Pediatrics, University of California San Diego, United States
Abstract:
Keywords:Cytokeratin-18   Fatty liver   NAFLD   NASH   Insulin resistance   Diabetes
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号